Irradiation alone for supraglottic larynx carcinoma: Can CT findings predict treatment results?

https://doi.org/10.1016/0360-3016(90)90562-XGet rights and content

Abstract

Between January 11982 and December 1986, 54 patients with squamous cell carcinoma of the supraglottic larynx were treated for cure with radiation therapy alone; all had a minimum 2-year follow-up. For 31 patients, highquality pretreatment CT scans were available for review. Scans were retrospectively evaluated by a single radiologist for the percentage of preepiglottic space involvement by tumor, the percentage of paralaryngeal space involvement, and the total tumor volume in cubic centimeters (cc). Volume was measured using a computer digitizer for each CT slice showing tumor. Results showed a significant difference in local control for tumors < 6 cc versus tumors ⪰ 6 cc 1518 or 613 or 46%; p = .038). This difference of both T stage and primary site. For T3 lesions, there was a trend toward decreased local control with increasing percentage of preepiglottic space involvement (0–25% = 85% local control; >25% = 60% local control; p = .384); in most cases, however, the amount of preepiglottic space involvement reflected tumor volume (0–25%, 812 or 67% of tumors were <6 cc; >25%, 710 or 70% of tumors were ≥6 cc). There was no clear association between degree of paraglottic space involvement and local control. Tumor volume did not correlate with complications of treatment. Because of the limited number of patients in the current study, conclusions should be considered preliminary. However, the data do suggest that pretreatment CT findings, particularly tumor volume, can predict the likelihood of local control with radiation therapy alone for squamous cell carcinoma of the supraglottic larynx.

References (26)

  • American Joint Committee on Cancer
  • C.R. Archer et al.

    Computed tomography of laryngeal cancer with histopathological correlation

    Laryngoscope

    (1982)
  • G.H. Fletcher et al.

    Causes of failure in irradiation of squamous cell carcinoma of the supraglottic larynx

    Radiology

    (1974)
  • G.H. Fletcher et al.

    The place of radiotherapy in the management of the squamous cell carcinoma of the supraglottic larynx

    Am. J. Roentgenol.

    (1970)
  • W.H. Friedman et al.

    Computed tomography vs laryngography: a comparison of relative diagnostic value

    Otolaryngol. Head Neck Surg.

    (1981)
  • R.W. Gilbert et al.

    Correlation of tumor volume with local control in laryngeal carcinoma treated by radiotherapy

    Ann. Otol. Rhinol. Laryngol.

    (1987)
  • H. Goepfert et al.

    Optimal treatment for the technically resectable squamous cell carcinoma of the supraglottic larynx

    Laryngoscope

    (1975)
  • R.T. Gregor et al.

    Computed tomography of the larynx: a clinical and pathologic study

    Head Neck Surg.

    (1981)
  • A.R. Harwood et al.

    Management of early supraglottic laryngeal carcinoma by irradiation with surgery in reserve

    Arch. Otolaryngol.

    (1983)
  • L.A. Hoover et al.

    Preoperative CT scan evaluation for laryngeal carcinoma: correlation with pathological findings

    Laryngoscope

    (1984)
  • J.H. Isaacs et al.

    CT scanning as an aid to selection of therapy in T2–T4 laryngeal cancer

    Head Neck Surg.

    (1988)
  • G.P. Katsantonis et al.

    The degree to which accuracy of preoperative staging of laryngeal carcinoma has been en hanced by computer tomography

    Otolaryngol. Head Neck Surg.

    (1986)
  • M.F. Mafee

    CT of the normal larynx

    Radiol. Clin. North Am.

    (1984)
  • Cited by (126)

    • Early supraglottic larynx cancer

      2017, Oral, Head and Neck Oncology and Reconstructive Surgery
    • Treatment/Comparative Therapeutics: Cancer of the Larynx and Hypopharynx

      2015, Surgical Oncology Clinics of North America
      Citation Excerpt :

      Bulky lesions with pretreatment airway compromise may not be appropriate for initial definitive RT. Tumor volume greater than 6 cubic centimeters on pretreatment CT is a poor prognostic indicator.25 Because of the high risk of lymphatic spread in supraglottic cancers, nodal basins in the neck, at minimum levels of II to IV, should be included in the radiation field.26

    • Larynx and Hypopharynx Cancer

      2015, Clinical Radiation Oncology
    • Pitfalls in the Staging of Cancer of the Laryngeal Squamous Cell Carcinoma

      2013, Neuroimaging Clinics of North America
      Citation Excerpt :

      Advantages include the lower risk of aspiration and the ability to address both necks without neck dissection. For patients with smaller supraglottic larynx cancers (ie, tumor volumes <6 mL), local control is 83% to 89%.32,33 After the Veterans Administration larynx trial proved that nonsurgical therapy produces survival rates equivalent to those for surgery plus adjuvant radiation,34 advanced laryngeal cancer (T3 or higher) not invading more than 1 cm of the base of tongue and without extralaryngeal spread is treated with concurrent chemoradiation.14

    • Larynx and Hypopharynx Cancer

      2012, Clinical Radiation Oncology: Third Edition
    • Neck dissection can be avoided after sequential chemoradiotherapy and negative post-treatment positron emission tomography-computed tomography in N2 Head and neck squamous cell carcinoma

      2011, Clinical Oncology
      Citation Excerpt :

      Drug delivery is also expected to be better in untreated well-vascularised lesions. Early studies have suggested an inverse relationship between tumour volume and local control with radiotherapy in laryngeal cancers and the same may be true for nodal control [20,21]. PF was used as this cohort of patients was treated before the publication of the TAX 324 and EORTC 24971/TAX 323 studies [22,23], which showed improved locoregional control and overall survival with the addition of docetaxel to PF (TPF) induction chemotherapy before definitive CRT or radiotherapy.

    View all citing articles on Scopus

    Presented at the 3lst Annual Scientific Meeting of the American Society of Therapeutic Radiology and Oncology, October 1–6, 1989, San Francisco, CA.

    Dept. of Radiation Oncology.

    Dept. of Radiology.

    View full text